Kate Rosenbluth

Kate Rosenbluth

Stanford University - Stanford / United States
Engineering & Technology / Bioengineering
AD Scientific Index ID: 1654567
person_outline Kate Rosenbluth's MOST POPULAR ARTICLES
1-) Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseG Mittermeyer, CW Christine, KH Rosenbluth, SL Baker, P Starr, P Larson, ...Human gene therapy 23 (4), 377-381, 20123082012
2-) Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to ironKE Hammond, M Metcalf, L Carvajal, DT Okuda, R Srinivasan, ...Annals of Neurology: Official Journal of the American Neurological …, 20083072008
3-) Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseasesKE Hammond, JM Lupo, D Xu, M Metcalf, DAC Kelley, D Pelletier, ...Neuroimage 39 (4), 1682-1692, 20082202008
4-) Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRIGA Kerchner, CP Hess, KE Hammond-Rosenbluth, D Xu, GD Rabinovici, ...Neurology 75 (15), 1381-1387, 20102192010
5-) Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson\'s diseaseRM Richardson, AP Kells, KH Rosenbluth, EA Salegio, MS Fiandaca, ...Molecular Therapy 19 (6), 1048-1057, 20111592011